[{"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0400257", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXAMETHASONE/BACTERIOSTATIC WATER  IONTOPHORESIS  0.5MG/5ML(0.1MG/ML) INJECTABL 30 ML (1 PRODUCT)    \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  DEXAMETHASONE SDPF (0.1ML SYRINGE, 31G, 5/16\" ) 0.4MG/ML INJECTABLE\t0.3 ML  \t0.5 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 10MG/ML (1%) INJECTABLE\t0.05 ML  \t1 ML  \t16 ML  \t  \t  \t  \t  \t2 ML  \t  \t24 ML  \t  \t  \t3 ML  \t  \t  \t32 ML  \t8 ML  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 4MG/ML (0.4%) INJECTABLE\t0.4 ML  \t2 ML  \t3 ML  \t  \t5 ML  \t6 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 80MG/ML (8%) INJECTABLE\t100 ML  \t40 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 8MG/ML (800MCG/0.1ML) INJECTABLE\t0.1 ML  DEXAMETHASONE SODIUM PHOSPHATE 40MG/ML INJECTABLE\t50 ML  DEXAMETHASONE SODIUM PHOSPHATE 4MG/ML INJECTABLE\t100 ML  \t  \t  \t180 MLS  \t  \t240 MLS  \t30 ML  \t60 ML  DEXAMETHASONE SODIUM PHOSPHATE IN BSS (P.F.) 10MG/ML (1%) INJECTABLE\t1 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE, 30ML VIAL** 4MG/ML INJECTABLE\t30 ML  DEXAMETHASONE SOLUTION - NACL, P.F. 0.1% OPHTHALMIC\t15 ML  \t  \t  DEXAMETHASONE, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 80MG/ML INJECTABLE\t0.35 ML  \t  \t0.7 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1498-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Nashville", "address_1": "110 20th Ave N", "reason_for_recall": "Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: 1905, Expiry: 4/30/14", "center_classification_date": "20140425", "distribution_pattern": "MO, TN, MS, WI", "state": "TN", "product_description": "Papaverine 60 mg, Phentolamine 4 mg, and Atropine 0.3 mg Solution, 10 mL Vial, Rx Only.  Not for Resale.  John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.", "report_date": "20140507", "classification": "Class III", "openfda": {}, "recalling_firm": "John W Hollis Inc", "recall_number": "D-1258-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67812", "termination_date": "20140501", "more_code_info": "", "recall_initiation_date": "20140317", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0375-2015", "product_description": "Total parenteral nutrition various strengths", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Failed dissolution specifications", "address_2": "Suite A", "product_quantity": "925 cartons (30 tablets in each carton)", "code_info": "Lot #140849", "center_classification_date": "20150616", "distribution_pattern": "Nationwide", "state": "OH", "product_description": "Lamivudine and Zidovudine Tablets USP 150mg/300mg 30 Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton of 30: NDC 68084-0416-21, Individual dose: NDC 68084-0416-11", "report_date": "20150624", "classification": "Class II", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-1140-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71219", "termination_date": "20151009", "more_code_info": "", "recall_initiation_date": "20150302", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as    chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD49426_1, EXP: 5/16/2014.", "address_2": "", "product_quantity": "400 Tablets", "code_info": "QUEtiapine FUMARATE, Tablet, 25 mg has the following code    Pedigree: AD49582_22, EXP: 4/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUEtiapine FUMARATE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65862048901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-716-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0005-2024", "product_description": "PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1", "product_quantity": "3,384 10 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275231, 17-275232, Exp. 10/2/2023; 17-275563, 17-275567, 17-275573, 17-275580, Exp. 10/8/2023; 17-275767, 17-275784, Exp. 10/10/2023;"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85995", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1445-2020", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86", "product_quantity": "3516 bottles", "reason_for_recall": "Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine", "recall_initiation_date": "20200706", "center_classification_date": "20200730", "termination_date": "20230608", "report_date": "20200805", "code_info": "Lot #: AA84106, Exp 9/2021"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0687-2022", "product_description": "Gentamicin Sulfate Ointment USP 0.1%, packaged as a) 15 grams tube, NDC 52565-090-15; b) 30 grams tube, NDC 52565-090-30, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "43,956 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 16878, 16912, Exp. 5/31/2023; b)16878, Exp. 5/21/2023"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0445-2022", "product_description": "Vitamin K (Vitamin K ) Oral Solution (PF), 5 mg/mL, 1mL per syringe, single Dose Syringe for Oral Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1132-03", "product_quantity": "757 syringes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "10-2021-11@6 01-09-2022 10/27/21 - 11/16/21 11-2021-01@8 01-30-2022 11/16/21 - 12/01/21", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1400-2022", "product_description": "ZZZQUIL NIGHT PAIN BERRY 12 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 903452", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0847-2019", "product_description": "Dr. King's SafeCare Rx First Aid for Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955177029, NDC 57955-1770-2", "product_quantity": "1229 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072815Q Exp. 07/18; 081815E Exp. 08/18; 091216F Exp. 09/19; 071317A Exp. 07/19"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065040"], "brand_name": ["CYCLOSPORINE"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-879", "68084-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["197553", "328160"], "spl_id": ["1857b1ea-c3f7-696a-e063-6394a90ad6eb"], "spl_set_id": ["a8e29b54-e4ab-4bb9-ab6c-e4414a3f025b"], "package_ndc": ["68084-879-95", "68084-879-25", "68084-921-95", "68084-921-25"], "original_packager_product_ndc": ["60505-0133", "60505-0134"], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "76484", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0490-2017", "product_description": "CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, Columbus, OH--- NDC 68084-921-25", "product_quantity": "454 cartons", "reason_for_recall": "Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities", "recall_initiation_date": "20170208", "center_classification_date": "20170224", "termination_date": "20171017", "report_date": "20170308", "code_info": "Lot 154527, exp 4/30/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1008-2017", "product_description": "fentaNYL (as citrate) 5 mcg/mL In 250 mL 0.9% Sodium Chloride  Injection Bag (Total fentaNYL Dose 1250 mcg/ 250 mL), Preservative Free, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0201-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170428@57 BUD: 7/27/2017; 20170428@58 BUD: 7/27/2017; 20170511@24 BUD: 8/9/2017"}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "8240 capsules", "code_info": "Lots: 04052018@16 Exp. 9/11/2018; 04242018@2 Exp. 10/21/2018; 05072018@8 Exp. 10/21/2018; 05302018@3 Exp. 10/22/2018; 06192018@9 Exp. 10/22/2018; 06192018@10 Exp. 12/15/2018; 06202018@12 Exp. 12/15/2018; 07022018@15 Exp. 12/15/2018; 07242018@2 Exp. 1/13/2018; 08312018@3 Exp. 2/6/2018", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Progesterone SR 200 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054 817-282-9376. NDC 99999-0018-74", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0241-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81344", "recalling_firm": "Bound Tree Medical, LLC", "address_1": "1420 Lakeside Parkway", "address_2": "N/A", "postal_code": "75208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0383-2019", "product_description": "curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 Epi Safe Administration Kit (8600-01101), 1 Epi Safe Training Kit (8600-01102), Rx Only, Distributed by Sarnova HC, LLC s family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Products, Inc. &  Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd. Dublin, OH 43016", "product_quantity": "1,283 kits (8 syringes per kit / 3 IFU's per kit)", "reason_for_recall": "Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.", "recall_initiation_date": "20181102", "center_classification_date": "20190118", "termination_date": "20200605", "report_date": "20190130", "code_info": "all lot numbers"}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92348", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Missouri only", "recall_number": "D-0638-2023", "product_description": "VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-284-25", "product_quantity": "1113 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230502", "center_classification_date": "20230518", "report_date": "20230524", "code_info": "Lot #: AC-016647, Exp. Date 06/28/2023"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug:  MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 00536406001, Pedigree: AD22865_13, EXP: 5/2/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes:   Pedigree: AD22865_16, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074929690.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-812-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "20 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: t10152013@22", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Acetylcysteine (PF) 20 % Opthalmic, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-410-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0326-2020", "product_description": "Viatrexx-Connectissue, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0090, NDC 73069-100-41.", "product_quantity": "24 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00001, Exp. May: 2020"}, {"status": "Terminated", "city": "Portland", "state": "ME", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77615", "recalling_firm": "Apothecary By Design", "address_1": "141 Preble St", "address_2": "N/A", "postal_code": "04101-2440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0924-2017", "product_description": "Progesterone Injection in Olive Oil With Benzyl Alcohol 10%, 50mg/mL, 10mL Multi-Dose Vial, Rx only, Apothecary by Design, 141 Preble Street, Portland, ME.", "product_quantity": "25 vials", "reason_for_recall": "Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.", "recall_initiation_date": "20170605", "center_classification_date": "20170628", "termination_date": "20171006", "report_date": "20170705", "code_info": "Lot #: 04192017@1, Exp 09/30/2017"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0282-2024", "product_description": "VANCOmycin HCl PF 1.5g added to 0.9% Sodium Chloride 250 mL IV bag, Item F3208, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-029-68.", "product_quantity": "7,548 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2331140, Exp. Date 02/08/2024; 2331188, Exp. Date 02/15/2024; 2331261, Exp. Date 03/05/2024; 2331287, Exp. Date 03/14/2024.", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Esmolol HCl  all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0837-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1003-2023", "product_description": "oxyTOCIN 30 units added to dextrose 5%/lactated ringers 500 mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6032-1", "product_quantity": "497 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-249712, Exp. 8/20/2023; 36-250059, Exp. 8/22/2023"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84422", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "CA, FL", "recall_number": "D-0617-2020", "product_description": "Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmaceuticals", "product_quantity": "316 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191202", "center_classification_date": "20191209", "termination_date": "20230509", "report_date": "20191218", "code_info": "Lot #: I2519H, Exp. 12/20; I2719O, Exp. 12/20; J1419O, Exp. 12/20; J2819L, Exp. 12/20", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83875", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0128-2020", "product_description": "Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05", "product_quantity": "13,130 bottles", "reason_for_recall": "CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190923", "center_classification_date": "20191007", "termination_date": "20230714", "report_date": "20191016", "code_info": "HD1862 4/30/2020  HP9438 9/30/2020  HP9439 9/30/2020  HP9440 9/30/2020"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1485-2022", "product_description": "Acetaminophen Oral Solution, 325 mg / 10.15 mL, 10.15 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152, NDC 0904-6739-71", "product_quantity": "848,500 cups", "reason_for_recall": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 20062A, 20067A, EXP Jun. 2022; 20092A, 20093A, EXP Sep. 2022; 20101A, 21110A, EXP Oct. 2022; 20108A, EXP Nov. 2022; 21012A, EXP Jan. 2023; 21044A, 21048B, EXP Apr. 2023; 21053A, EXP May. 2023; 21063B, 21068B, EXP Jun. 2023; 21084B, EXP Jul. 2023; 21090A, EXP Aug. 2023; 21119A, EXP Nov. 2023; 21122B, EXP Dec. 2023; 22001B, 22006A, EXP Jan. 2024; 22017B, EXP Mar. 2024"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77484", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1051-2017", "product_description": "Alka-Seltzer  Gold (1000 mg Anhydrous citric acid, 344 mg Antacid Potassium bicarbonate, 1050 mg Antacid Sodium bicarbonate/Antacid) Effervescent Tablets, 36-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981,  UPC 016500041085", "product_quantity": "56,064 36-count cartons", "reason_for_recall": "Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.", "recall_initiation_date": "20170330", "center_classification_date": "20170801", "termination_date": "20200108", "report_date": "20170809", "code_info": "BTAHGR0; Exp. 05/19  BTAHGR1; Exp. 05/19  BTAHGR2; Exp. 05/19  BTAJ0K3; Exp. 07/19"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0217-2016", "product_description": "ESTRIOL (E3) : ESTRADIOL (E2) (Estradiol (E2) Trit (Yellow)) : PROGEST (Progesterone USP) : TESTO (Testosterone USP) W/V (weight/volume) 2 :0.1 : 35 : 0.5 MG/ML Transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only,   The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "6 (10mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01132015:27@20, Exp 7/12/2015"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1701-2019", "product_description": "RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0923-02", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-732-2015", "product_description": "Indocyanine Green active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "271 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-616-2015", "product_description": "Darunavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "110 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0139-2021", "product_description": "CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot #1110202004 Exp 12/10/2020"}, {"country": "United States", "city": "Corpus Christi", "address_1": "3333 S Padre Island Dr", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.", "address_2": "Suite 102", "product_quantity": "1424 bottles", "code_info": "All lots remaining within expiry.", "center_classification_date": "20171220", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.", "report_date": "20171227", "classification": "Class I", "openfda": {}, "recalling_firm": "EZWeightLossTX LLC", "recall_number": "D-0122-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77817", "termination_date": "20210210", "more_code_info": "", "recall_initiation_date": "20170724", "postal_code": "78415-2904", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Salicylic Acid Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona  85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0484-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209482"], "brand_name": ["TRELEGY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0887", "0173-0893"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_id": ["676a0120-5f94-4470-b936-2c8cfb32d3fc"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "package_ndc": ["0173-0887-10", "0173-0887-14", "0173-0887-61", "0173-0893-10", "0173-0893-14", "0173-0893-61"], "is_original_packager": [true], "unii": ["40AHO2C6DG", "7AN603V4JV", "JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0481-2021", "product_description": "TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMEDIDINIUM AND VILANTEROL INHALATION POWDER) 100-62.5-25MCG 60; NDC/UPC 0173-0893-10; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "4065 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "FN2J"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["TINACTIN"], "generic_name": ["TOLNAFTATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-4162"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TOLNAFTATE"], "rxcui": ["705934", "705936"], "spl_id": ["289f4a63-0291-b92a-e063-6394a90a6625"], "spl_set_id": ["5f95be36-6efa-4dfb-9a40-88f4ce1de2b3"], "package_ndc": ["11523-4162-1", "11017-410-00"], "is_original_packager": [true], "upc": ["0311017410004", "311017410004"], "unii": ["06KB629TKV"]}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0242-2022", "product_description": "Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981", "product_quantity": "738,432 cans", "reason_for_recall": "cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # (a) TN004BW, EXP 7/31/2022,   (b) TN00678, EXP 8/31/2022; TN00679, EXP 9/30/2022;", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Neostigmine Methylsulfate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0839-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Murrieta", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85351", "recalling_firm": "Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy", "address_1": "41538 Eastman Dr Ste A", "address_2": "N/A", "postal_code": "92562-8007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Distribution list includes addresses in the following states: CA, ME, TX", "recall_number": "D-1098-2020", "product_description": "Testosterone Cypionate In Sesame Oil 200mg/ml, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562  951-304-9530", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200326", "center_classification_date": "20200406", "termination_date": "20240129", "report_date": "20200415", "code_info": "Lot #: 11152019@41,Expires after 04-07-2020; Lot # 12042019@12, Expires after 04-26-2020; Lot # 12172019@9, Expires after 05-09-2020; Lot # 01032020@49, Expires after 05-26-2020; Lot # 01162020@55, Expires after 06-08-2020"}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-253-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 75 mcg,  packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles ( NDC 60793-852-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "37809 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a)  66369B, Exp. 10/13; 66679B, Exp. 11/13; 66850B, Exp. 12/13; b) 66676B, 66732B, Exp. 12/13; 67136B, Exp. 03/14"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0492-2021", "product_description": "LITHIUM CARB 150MG 100; NDC/UPC 54252625; RX; CAPSULES", "product_quantity": "298 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AB1024A"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-800-2015", "product_description": "Minoxidil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4600 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "67322", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1033-2014", "product_description": "Propofol Injectible Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, packaged in 5 Units x 20 mL per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.", "product_quantity": "126,425 vials", "reason_for_recall": "Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.", "recall_initiation_date": "20131212", "center_classification_date": "20140123", "termination_date": "20141016", "report_date": "20140129", "code_info": "Lot #: 27-568-DJ*, Exp 03/15, Note * may be followed by 01", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0295-2018", "product_description": "Medline General Purpose Instrument Set, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "3,300 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDS1014; Lots 17GB3416; 176B2045", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210705"], "brand_name": ["FENOFIBRATE"], "generic_name": ["FENOFIBRATE"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "product_ndc": ["27241-118", "27241-119", "27241-120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FENOFIBRATE"], "rxcui": ["200311", "310288", "310289"], "spl_id": ["2dffe879-0f18-4961-b1a9-0d69565a04a6"], "spl_set_id": ["da2f0ba4-7c16-4fb0-bc1c-45540e8fefbf"], "package_ndc": ["27241-118-04", "27241-118-05", "27241-119-04", "27241-119-05", "27241-120-04", "27241-120-05"], "is_original_packager": [true], "upc": ["0327241119040", "0327241118043", "0327241120046"], "nui": ["N0000175596", "N0000175375", "M0199111"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "pharm_class_cs": ["PPAR alpha [CS]"], "unii": ["U202363UOS"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0407-2021", "product_description": "FENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULES", "product_quantity": "106 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "PA03410"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0810-2019", "product_description": "Dr. King's SafeCare Rx Leg Cramps & Spasms, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955043522, NDC 57955-0435-2", "product_quantity": "296 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072015J Exp. 07/18; 051716H Exp. 05/19; 081016B Exp. 08/19; 092617B Exp. 10/19"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85212", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1090-2020", "product_description": "ePHEDrine Sulfate 5 mg per mL 25 mg per 5 mL, in 0.9% Sodium Chloride, 5 mL BD Syringe, For IV Use, Rx Only, PharMEDium 913 N. Davis Ave. Cleveland, MS 98732 NDC 71030-003-02", "product_quantity": "1500 units", "reason_for_recall": "Firm is recalling 46 lots of various products because of a lack of sterility assurance.", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20250214", "report_date": "20200415", "code_info": "193510031D, Exp 3/17/2020"}, {"status": "Terminated", "city": "Maryland Heights", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078098"], "brand_name": ["TECHNETIUM TC 99M SESTAMIBI"], "generic_name": ["TECHNETIUM TC 99M SESTAMIBI"], "manufacturer_name": ["Curium US LLC"], "product_ndc": ["69945-092"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE"], "spl_id": ["4b00526c-6250-49d7-ba34-459ef89c8f43"], "spl_set_id": ["4110d0f4-3bcf-4688-a39f-42a81064c796"], "package_ndc": ["69945-092-20", "69945-092-40"], "is_original_packager": [true], "unii": ["N6OU7HJ70P"]}, "product_type": "Drugs", "event_id": "95839", "recalling_firm": "Curium US, LLC", "address_1": "2703 Wagner Pl", "address_2": "", "postal_code": "63043-3421", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Canada.", "recall_number": "D-0164-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate -  0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg.  The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only,  Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40", "product_quantity": "5,160 vials (172 kits 30 vials/kit)", "reason_for_recall": "Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product", "recall_initiation_date": "20241126", "center_classification_date": "20241226", "termination_date": "20251010", "report_date": "20250101", "code_info": "Lot 092-24006, Catalog # N092D0, Exp 06/15/2026", "more_code_info": ""}, {"status": "Completed", "city": "Manassas", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94981", "recalling_firm": "Granules Consumer Health Inc.", "address_1": "7413 Cushing Rd Ste 145", "address_2": "", "postal_code": "20109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalled lot was distributed to one distributor in IL who may have further distributed the product to the retail level.", "recall_number": "D-0627-2024", "product_description": "Acetaminophen, USP 500mg, Pain Reliever/Fever Reducer, Extra Strength, Rapid Release Gelcaps, packaged in a 225-count HDPE bottle, further packaged in a carton, Distributed by Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015, Made in India", "product_quantity": "21,192 Bottles", "reason_for_recall": "Label mix-up: Carton incorrectly labeled.", "recall_initiation_date": "20240718", "center_classification_date": "20240806", "report_date": "20240814", "code_info": "Lot #: 31670346AA, Exp 12/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018609"], "brand_name": ["HEPARIN SODIUM IN SODIUM CHLORIDE"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0424", "0338-0431", "0338-0433", "0338-0428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658690", "1658692"], "spl_id": ["68b37381-6db4-4ac0-ba6b-3204add02665"], "spl_set_id": ["0d929726-76c3-48fc-b4e7-fd06409f9fb3"], "package_ndc": ["0338-0431-03", "0338-0433-04", "0338-0424-18", "0338-0428-12"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "95102", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "25212 W Il Route 120", "address_2": "", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0649-2024", "product_description": "Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA,  NDC 0338-0433-04", "product_quantity": "44,208 containers", "reason_for_recall": "Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.", "recall_initiation_date": "20240801", "center_classification_date": "20240830", "report_date": "20240911", "code_info": "Lot # N008235, Exp 8/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1006-2017", "product_description": "BUPIVacaine HCl 0.125% In 250 mL 0.9% Sodium Chloride Bag, Preservative Free (Total Dose Bupivacaine 312.5 mg per 250 mL), Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0062-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170502@32 BUD: 7/31/2017"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0286-2016", "product_description": "Triamcinolone diacetate USP (40 mg/mL), 30 mL Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3205-06", "product_quantity": "13,843 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot: 20150204@7 BUD: 9/29/2015, 20150304@1 BUD: 9/29/2015, 20150604@23 BUD: 10/3/2015, 20150807@50 BUD: 1/4/2016, 20150906@23 BUD: 12/6/2015, 20150906@24 BUD: 12/6/2015, 20152005@42 BUD: 11/16/2015, 20152206@52 BUD: 12/19/2015, 20152406@14 BUD: 12/21/2015, 20152603@26 BUD: 9/22/2015, 20152804@20 BUD: 10/25/2015, 20152904@20 BUD: 10/26/2015, 20152907@8 BUD: 1/25/2016, 20151603@56 BUD: 9/12/2015, 20152406@30 BUD: 12/21/2015"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "126 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 10112013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Glutathione PF, 60 mg/mL inhalation, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-423-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79803", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0699-2018", "product_description": "Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265  Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10", "product_quantity": "4555 syringes", "reason_for_recall": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.", "recall_initiation_date": "20180411", "center_classification_date": "20180426", "termination_date": "20200915", "report_date": "20180502", "code_info": "Lots: MOR030518IJDSA, MOR030518IJDSB, MOR030518IJDSC, MOR030518IJDSD, MOR030518IJDSE BUD: 06/03/2018;"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "4 vials", "code_info": "Lot # t12-21-2016@110, Exp 6/20/2017; t12-27-2016@84, Exp 6/26/2017; t12-30-2016@74, Exp 7/2/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PAPAVERINE/PHENT 5ML MDV 30/1MG/ML INJ, Injection, 30mg/1mg/mL, Rx only, 5mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0730-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0542-2020", "product_description": "Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219.     NDC's   67751-152-01  67751-152-02", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-196-2014", "product_description": "Marcaine .2% NS 300ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "233 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-465-2015", "product_description": "Bayshore Medical Center (TX) 10% Dextrose Starter Neo TPN, Trophamine 2.4% , Dextrose 10%, Additives: heparin PF 1 unit(s)/ml, Calcium Gluconate 2.3mEq/dL, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "3 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74776, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74776-0-3-R, Disp ID: 37-1124585"}, {"status": "Terminated", "city": "Bedford", "state": "NH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72233", "recalling_firm": "Bedford Pharmacy", "address_1": "209 Route 101", "address_2": "N/A", "postal_code": "03110-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NH, MA", "recall_number": "D-0043-2016", "product_description": "Methylcobalamin (Bacteriostatic) 1 mg/mL Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150922", "center_classification_date": "20151015", "termination_date": "20160608", "report_date": "20151021", "code_info": "Lot #: 08132015@17, Exp 09/27/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0347-2015", "product_description": "Ertapenem various strength in normal saline bags", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:  0384839      0384839", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "ISOSULFAN BLUE 1% INJECTABLE\t10 ML  \t  \t15 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1550-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090145"], "brand_name": ["PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID"], "generic_name": ["PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3560"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["800915"], "spl_id": ["46e37694-3149-46b3-a949-fad3ccbb8052"], "spl_set_id": ["475a06c6-f295-406c-a110-f1497cf51566"], "package_ndc": ["0093-3560-19", "0093-3560-26", "0093-9044-19", "0093-9043-19"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94924", "recalling_firm": "Novel Laboratories, Inc. d.b.a Lupin Somerset", "address_1": "400 Campus Dr", "address_2": "", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0628-2024", "product_description": "PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.", "product_quantity": "13,200 cartons", "reason_for_recall": "Defective container: potential for non-sealed pouches which can lead to product leakage.", "recall_initiation_date": "20240702", "center_classification_date": "20240807", "termination_date": "20250428", "report_date": "20240814", "code_info": "Lot #S300542, exp. date June 30, 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "88309", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0750-2021", "product_description": "Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.", "product_quantity": "37560 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification: Some tablets are shaved", "recall_initiation_date": "20210719", "center_classification_date": "20210818", "termination_date": "20221221", "report_date": "20210825", "code_info": "Lot #: T2000471, exp date 09/2023"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91770", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ, OH, MS.", "recall_number": "D-0467-2023", "product_description": "Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC 16714-0039-02, Manufactured for: NorthStar Rx LLC., Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, c) 100 tablets per bottle, NDC 70710-1351-01, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.", "product_quantity": "21,936/30 count bottles and 33,096/100 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.", "recall_initiation_date": "20230224", "center_classification_date": "20230314", "termination_date": "20250701", "report_date": "20230322", "code_info": "Lot #s: a) E203821, Exp. 05/2024; b) E203822, Exp. 05/2024, E206186, Exp. 10/2024; c) E203820, Exp. 05/2024."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090693"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-782", "60687-793"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993541", "993557"], "spl_id": ["37b2800f-32bb-1c88-e063-6294a90acfe7"], "spl_set_id": ["8dab6d17-bf41-4a28-90db-b66959c0e143"], "package_ndc": ["60687-782-11", "60687-782-01", "60687-793-11", "60687-793-21"], "original_packager_product_ndc": ["68180-319", "68180-320"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "94891", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0590-2024", "product_description": "buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.", "product_quantity": "2,484 cartons", "reason_for_recall": "Failed Dissolution Specifications; the product is dissolving faster than the specified limits.", "recall_initiation_date": "20240624", "center_classification_date": "20240708", "report_date": "20240717", "code_info": "Lot 1017343, Exp. 12/31/2025"}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89986", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States including Guam and the Northern Mariana Islands.", "recall_number": "D-0848-2022", "product_description": "Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64", "product_quantity": "81,757 bottles", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.", "recall_initiation_date": "20220421", "center_classification_date": "20220505", "report_date": "20220511", "code_info": "Lots: 15597, Exp.: 05/31/2023; 16305, Exp.: 12/23/2023; 16334, Exp.: 01/31/2024; 16340, Exp.: 01/31/2024; 16346 Exp.: 01/31/2024; 16356, Exp.: 01/31/2024; 16357, Exp.: 01/31/2024"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1141-2022", "product_description": "Vaccinotoxinum, Potency: 32X, 11C, 30C, Liquid Pellets, Rx only,  Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "2 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 2512K, 20280", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A3804 Exp 12/31/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Diphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-723-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Toradol 60mg/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0461-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Philadelphia", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71684", "recalling_firm": "Mutual Pharmaceutical Company,  Inc.", "address_1": "1100 Orthodox St", "address_2": "N/A", "postal_code": "19124-3168", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nartionwide", "recall_number": "D-1282-2015", "product_description": "Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA, NDC 53489-217-01", "product_quantity": "20,892 bottles", "reason_for_recall": "cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer", "recall_initiation_date": "20150709", "center_classification_date": "20150730", "termination_date": "20161013", "report_date": "20150805", "code_info": "Lot #: 6676701 and 6676801, exp 1/17"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-331-2016", "product_description": "Testosterone CYP/ENAN/PROP Injection in Cottonseed Oil, 66.6 mg/66.6. mg/66.6 mg/mL, 5 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 060415, Exp 09/04/2015"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1003-2016", "product_description": "MYERS' COCKTAIL, packaged in 37 mL vials, Rx only,  Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01112016:29@20, Exp. 01/19/2016; Lot #:01202016:  85@9, Exp. 01/27/2016; Lot #: 01222016: 56@17, Exp. 01/29/2016; Lot #: 01222016:36@49, Exp.02/02/2016; Lot #: 01262016:72@12, Exp.02/02/2016; Lot #: 01262016: 56@58, Exp.02/03/2016; Lot #: 02052016:89@26, Exp.03/02/2016; Lot #: 02112016:55@39, Exp.03/03/2016; Lot #: 02102016:  95@17, Exp. 03/08/2016; Lot #: 02222016:39@46, Exp. 03/15/2016; Lot #: 04222016:40@48, Exp.03/16/2016; Lot #: 02262016:53@13, Exp.03/24/2016; Lot #: 03072016:  01@14, Exp. 03/29/2016; Lot #: 03082016:40@11, Exp.03/30/2016; Lot #: 3012016:90@30, Exp.04/07/2016; Lot #: 03012016:78@13, Exp.04/18/2016; Lot #: 03222016:  19@17     04/13/2016; Lot #: 0331201661@40, Exp.04/21/2016; Lot #: 04132016:89@17, Exp.  05/06/2016; Lot #: 04272016:35@45, Exp. 05/20/2016; Lot #: 04292016:70@27, Exp.05/23/2016."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1380-2016", "product_description": "10 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride,\t 250 mL in 250 mL Baxter Intravia Bag, Service Code 2K8142, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-142-02", "product_quantity": "N/A", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160460189M , Exp. Date 5/10/2016 ;  Lot Number 160480179M , Exp. Date 5/12/2016 ;  Lot Number 160520105M , Exp. Date 5/15/2016 ;  Lot Number 160530291M , Exp. Date 5/17/2016 ;  Lot Number 160540130M , Exp. Date 5/17/2016 ;  Lot Number 160550186M , Exp. Date 5/19/2016 ;  Lot Number 160560087M , Exp. Date 5/19/2016 ;  Lot Number 160590074M , Exp. Date 5/23/2016 ;  Lot Number 160620037M , Exp. Date 5/25/2016 ;  Lot Number 160630028M , Exp. Date 5/26/2016 ;  Lot Number 160660039M , Exp. Date 5/29/2016 ;  Lot Number 160730059M , Exp. Date 6/6/2016 ;  Lot Number 160740234M , Exp. Date 6/7/2016 ;  Lot Number 160800073M , Exp. Date 6/12/2016 ;  Lot Number 160820049M , Exp. Date 6/14/2016 ;  Lot Number 160890045M , Exp. Date 6/21/2016 ;  Lot Number 160970197M , Exp. Date 6/30/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Joseph", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["HILLYARD ALCOHOL FREE FOAMING INSTANT HAND SANITIZER"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["Hillyard GMP"], "product_ndc": ["76402-403"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1038799"], "spl_id": ["25ec5420-cf0c-4632-a9a1-db09708d8666"], "spl_set_id": ["a066bd4e-8f1d-4dfe-8754-fc7fd5ae48f9"], "package_ndc": ["76402-403-06", "76402-403-03", "76402-403-02", "76402-403-82"], "is_original_packager": [true], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "64020", "recalling_firm": "Hillyard GMP", "address_1": "421 N 2nd St", "address_2": "", "postal_code": "64504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distribution nationwide", "recall_number": "D-140-2013", "product_description": "HILLYARD, Alcohol Free Foaming Instant Hand Sanitizer, Benzalkonium Chloride 0.10%, 1.25 L plastic bottle, OTC, HILLYARD IDUSTRIES, St. Joseph, MO. 64502 NDC 76402-403-03", "product_quantity": "2,139 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: The product may be contaminated with bacteria.", "recall_initiation_date": "20121228", "center_classification_date": "20130131", "termination_date": "20140129", "report_date": "20130206", "code_info": "Lot 1025554, Exp: 03/14 and Lot 1030652, Exp: 09/14", "more_code_info": ""}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67420", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1175-2014", "product_description": "Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical Oil (Body Oil) 4 fl. oz., Rx only  Manufactured and Distributed by: Hill Dermaceuticals, Inc. Sanford, Florida 32773 NDC 28105-150-04", "product_quantity": "8,734 bottles", "reason_for_recall": "Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "recall_initiation_date": "20140131", "center_classification_date": "20140324", "termination_date": "20150203", "report_date": "20140402", "code_info": "13D010A exp. 10/14."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1423-2016", "product_description": "5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride    Service Code\t2K8135\t,\tNDC\t61553-135-48\t,\t100 ml in 150 ml Baxter Intravia Bag \t;  Service Code\t2K8136\t,\tNDC\t61553-136-02\t,\t250 ml in 250 ml Baxter Intravia Bag \t;  Service Code\t2K8447\t,\tNDC\t61553-447-25\t,\t500 ml in 500 ml Baxter Intravia Bag \t;  Service Code\t2K9135\t,\tNDC\t61553-135-10\t,\t350 ml in 500 ml Baxter Intravia Bag \t;  Service Code\t2K9915\t,\tNDC\t61553-915-97\t,\t250 ml in 250 ml Baxter Intravia Bag \t;  Service Code\t4J8136\t,\tNDC\t61553-136-97\t,\t250 ml in 250 ml Baxter Intravia Bag \t;  Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141,", "product_quantity": "3,474 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2H8136 , Lot Number 160390196M , Exp. Date 5/9/2016 ;  Service Code 2H8136 , Lot Number 160400231M , Exp. Date 5/10/2016 ;  Service Code 2H8136 , Lot Number 160410114M , Exp. Date 5/11/2016 ;  Service Code 2H8136 , Lot Number 160460187M , Exp. Date 5/16/2016 ;  Service Code 2H8136 , Lot Number 160490237M , Exp. Date 5/19/2016 ;  Service Code 2H8136 , Lot Number 160520172M , Exp. Date 5/22/2016 ;  Service Code 2H8136 , Lot Number 160530288M , Exp. Date 5/23/2016 ;  Service Code 2H8136 , Lot Number 160600186M , Exp. Date 5/30/2016 ;  Service Code 2H8136 , Lot Number 160630207M , Exp. Date 6/2/2016 ;  Service Code 2H8136 , Lot Number 160670243M , Exp. Date 6/6/2016 ;  Service Code 2H8136 , Lot Number 160730070M , Exp. Date 6/11/2016 ;  Service Code 2H8136 , Lot Number 160740213M , Exp. Date 6/13/2016 ;  Service Code 2H8136 , Lot Number 160810151M , Exp. Date 6/20/2016 ;  Service Code 2H8136 , Lot Number 160830114M , Exp. Date 6/22/2016 ;  Service Code 2H8136 , Lot Number 160880266M , Exp. Date 6/27/2016 ;  Service Code 2H8136 , Lot Number 160950223M , Exp. Date 7/4/2016 ;  Service Code 2H8136 , Lot Number 160960179M , Exp. Date 7/5/2016 ;  Service Code 2H8136 , Lot Number 161080119M , Exp. Date 7/17/2016 ;  Service Code 2K8135 , Lot Number 160390318M , Exp. Date 5/9/2016 ;  Service Code 2K8135 , Lot Number 160450256M , Exp. Date 5/15/2016 ;  Service Code 2K8135 , Lot Number 160520144M , Exp. Date 5/22/2016 ;  Service Code 2K8135 , Lot Number 160660248M , Exp. Date 6/5/2016 ;  Service Code 2K8135 , Lot Number 160730089M , Exp. Date 6/12/2016 ;  Service Code 2K8135 , Lot Number 160840235M , Exp. Date 6/23/2016 ;  Service Code 2K8135 , Lot Number 160950175M , Exp. Date 7/4/2016 ;  Service Code 2K8136 , Lot Number 160470209M , Exp. Date 5/11/2016 ;  Service Code 2K8136 , Lot Number 160490159M , Exp. Date 5/13/2016 ;  Service Code 2K8136 , Lot Number 160560128M , Exp. Date 5/20/2016 ;  Service Code 2K8136 , Lot Number 160600250M , Exp. Date 5/24/2016 ;  Service Code 2K8136 , Lot Number 160660268M , Exp. Date 5/30/2016 ;  Service Code 2K8136 , Lot Number 160730128M , Exp. Date 6/6/2016 ;  Service Code 2K8136 , Lot Number 160770110M , Exp. Date 6/10/2016 ;  Service Code 2K8136 , Lot Number 160810309M , Exp. Date 6/14/2016 ;  Service Code 2K8136 , Lot Number 160840046M , Exp. Date 6/17/2016 ;  Service Code 2K8136 , Lot Number 160890166M , Exp. Date 6/22/2016 ;  Service Code 2K8136 , Lot Number 160970110M , Exp. Date 6/30/2016 ;  Service Code 2K8136 , Lot Number 161080316M , Exp. Date 7/11/2016 ;  Service Code 2K8447 , Lot Number 160480124M , Exp. Date 5/12/2016 ;  Service Code 2K8447 , Lot Number 160560102M , Exp. Date 5/19/2016 ;  Service Code 2K8447 , Lot Number 160620043M , Exp. Date 5/25/2016 ;  Service Code 2K8447 , Lot Number 160820219M , Exp. Date 6/15/2016 ;  Service Code 2K8945 , Lot Number 160460179M , Exp. Date 5/6/2016 ;  Service Code 2K8945 , Lot Number 160680052M , Exp. Date 5/28/2016 ;  Service Code 2K8945 , Lot Number 160890253M , Exp. Date 6/19/2016 ;  Service Code 2K8984 , Lot Number 160490124M , Exp. Date 5/9/2016 ;  Service Code 2K8984 , Lot Number 160530219M , Exp. Date 5/14/2016 ;  Service Code 2K8984 , Lot Number 160550193M , Exp. Date 5/15/2016 ;  Service Code 2K8984 , Lot Number 160620141M , Exp. Date 5/23/2016 ;  Service Code 2K8984 , Lot Number 160690159M , Exp. Date 5/30/2016 ;  Service Code 2K8984 , Lot Number 160750189M , Exp. Date 6/5/2016 ;  Service Code 2K8984 , Lot Number 160820117M , Exp. Date 6/11/2016 ;  Service Code 2K8984 , Lot Number 161080172M , Exp. Date 7/8/2016 ;  Service Code 2K9135 , Lot Number 160520112M , Exp. Date 5/16/2016 ;  Service Code 2K9135 , Lot Number 160600209M , Exp. Date 5/24/2016 ;  Service Code 2K9135 , Lot Number 160620189M , Exp. Date 5/26/2016 ;  Service Code 2K9135 , Lot Number 160660051M , Exp. Date 5/29/2016 ;  Service Code 2K9135 , Lot Number 160830126M , Exp. Date 6/15/2016 ;  Service Code 2K9135 , Lot Number 160890180M , Exp. Date 6/22/2016 ;  Service Code 2K9135 , Lot Number 160910126M , Exp. Date 6/24/2016 ;  Service Code 2K9915 , Lot Number 160620026C , Exp. Date 5/26/2016 ;  Service Code 2K9915 , Lot Number 160740050C , Exp. Date 6/7/2016 ;  Service Code 2K9915 , Lot Number 160810059C , Exp. Date 6/15/2016 ;  Service Code 2T6135 , Lot Number 160400229M , Exp. Date 5/10/2016 ;  Service Code 2T6135 , Lot Number 160450178M , Exp. Date 5/15/2016 ;  Service Code 2T6135 , Lot Number 160490241M , Exp. Date 5/19/2016 ;  Service Code 2T6135 , Lot Number 160620220M , Exp. Date 6/1/2016 ;  Service Code 2T6135 , Lot Number 160680050M , Exp. Date 6/6/2016 ;  Service Code 2T6135 , Lot Number 160810281M , Exp. Date 6/20/2016 ;  Service Code 2T6135 , Lot Number 160940052M , Exp. Date 7/2/2016 ;  Service Code 2T6135 , Lot Number 160950068M , Exp. Date 7/4/2016 ;  Service Code 4J8136 , Lot Number 160460142M , Exp. Date 5/10/2016 ;  Service Code 4J8136 , Lot Number 160680034M , Exp. Date 5/31/2016 ;  Service Code 4J8136 , Lot Number 160740033M , Exp. Date 6/6/2016 ;  Service Code 4J8136 , Lot Number 160880020M , Exp. Date 6/20/2016 ;  Service Code 4J8136 , Lot Number 160950048M , Exp. Date 6/27/2016 ;", "more_code_info": ""}, {"status": "Completed", "city": "Morton Grove", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88629", "recalling_firm": "Morton Grove Pharmaceuticals, Inc.", "address_1": "6451 Main St", "address_2": "", "postal_code": "60053-2633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and China", "recall_number": "D-0815-2021", "product_description": "Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate 10 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-606-16", "product_quantity": "14,904 bottles", "reason_for_recall": "CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.", "recall_initiation_date": "20210903", "center_classification_date": "20210920", "report_date": "20210929", "code_info": "Lot #: UV1198", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88370", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0775-2021", "product_description": "Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, NDC 70199-014-01", "product_quantity": "4,587 bottles", "reason_for_recall": "CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC)  for an excipient batch of Dibasic Calcium Phosphate.", "recall_initiation_date": "20210729", "center_classification_date": "20210827", "termination_date": "20221104", "report_date": "20210908", "code_info": "1408822A, exp. date 08/2023 (labeler - Casper)"}, {"country": "United States", "city": "Morgantown", "address_1": "781 Chestnut Ridge Rd", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.", "address_2": "", "product_quantity": "9225 Bottles", "code_info": "Lot # 2004069, Expiry: 09/2014; Lot #: 2004070, Expiry: 09/2014.", "center_classification_date": "20140818", "distribution_pattern": "U.S. Nationwide", "state": "WV", "product_description": "Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only.  Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-5445-91.", "report_date": "20140827", "classification": "Class III", "openfda": {}, "recalling_firm": "Mylan Pharmaceuticals Inc.", "recall_number": "D-1539-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "68642", "termination_date": "20151009", "more_code_info": "", "recall_initiation_date": "20140620", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0682-2020", "product_description": "BUP 10MG/HYDROM 15MG/SUF 200MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@4 Exp. 12/25/2019", "more_code_info": ""}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "BI-EST Creams, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0500-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; VENLAFAXINE Tablet, 25 mg may be potentially mislabeled as    OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD65457_22, EXP: 5/24/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "VENLAFAXINE Tablet, 25 mg has the following code    Pedigree: AD67989_4, EXP: 11/30/2013.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VENLAFAXINE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714031101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-516-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0761-2018", "product_description": "Boost VHC Oral Liquid VAN #27 NDC 43900-0182-15 27 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82196", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1005-2019", "product_description": "Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-130-07", "product_quantity": "134495 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.", "recall_initiation_date": "20190225", "center_classification_date": "20190314", "termination_date": "20210712", "report_date": "20190320", "code_info": "Lot #: BTN703A, BTN704A Exp Feb-19; BTN705A, BTN706A, Exp May-19; BTN707A, Exp Jun-19; BTN810A, Exp Jun-20;  BTN811A, BTN812A Exp Aug-20; BTN813A, BTN814A, Exp Sep-20; BTN802A, BTN802B, BTN803A, BTN804A, Exp Dec-19; BTN805A, BTN806A, BTN807A, BTN807B, Exp Feb-20;  BTN808A, Exp Apr-20; BTN809A, BTN810A,  Exp Jun-20; BTN811A, BTN812A, Exp Aug-20; BTN813A, BTN814A, Exp Sep-20."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:  0396686    0404360    0390749    0401266    0401266    0390749    0387231    0404358", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PROCAINE HCL, P.F. 1% INJECTABLE\t1000 ML  \t180 ML;  PROCAINE HCL, P.F. 2% INJECTABLE\t300 ML  \t  \t360 ML  \t450 ML;  PROCAINE HCL, P.F. 8% INJECTABLE\t20 ML  \t60 ML  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1607-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0423-2022", "product_description": "Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446, NDC 05446-1680-01", "product_quantity": "1773 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "10-2021-25@5 12/09/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0124-2023", "product_description": "QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 50mcg/40mg/4mg/0.4mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12082022@8, Exp 1/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["POVIDONE-IODINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-938"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["211747"], "spl_id": ["41c65656-ff98-67e5-e063-6394a90a6079"], "spl_set_id": ["2b95078e-2caf-7005-e054-00144ff88e88"], "package_ndc": ["53329-938-06", "53329-938-08", "53329-938-23", "53329-938-25", "53329-938-04"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "79267", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "N/A", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Curacao", "recall_number": "D-0546-2018", "product_description": "PVP Scrub Solution, Povidone Iodine, 7.5% (equivalent to 0.75% available iodine), 4 FL OZ bottle, Manufactured in USA by Medline Industries, Inc., Northfield, IL 60093; Product Number MDS093945; NDC 53329-938-04", "product_quantity": "67,104 bottles", "reason_for_recall": "Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.", "recall_initiation_date": "20180215", "center_classification_date": "20180226", "termination_date": "20200429", "report_date": "20180307", "code_info": "Lot #: 16EJ0023, Exp 04/18"}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0326-2018", "product_description": "Tatiomax Gluatathione Whitening kits, 1400mg vials, Made in Japan", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Terminated", "city": "Chino", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82857", "recalling_firm": "La Fresh Group, Inc.", "address_1": "4651 Schaefer Ave", "address_2": "N/A", "postal_code": "91710-5542", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Firm's website sales and www.Amazon.com", "recall_number": "D-1566-2019", "product_description": "LA FRESH travel lite Sunnyside Lotion Wipe silky, non-greasy formula smooth, soft & moisturizing featuring titanium dioxide, 1 wipe individually wrapped packet, 4.75\" x 5.75\" (12.0 cm x 14.6 cm) Ingredients: Water, Dimethicone, Dimethiconol, Titanium Dioxide, Benzophenone-3, Octinoxate, Ethylhexylglycerine, Phenoxyethanol, Distributed by La Fresh Group, Inc. Chino, CA 91710 www.LaFreshGroup.com", "product_quantity": "83,050 packets", "reason_for_recall": "Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.", "recall_initiation_date": "20190715", "center_classification_date": "20190731", "termination_date": "20210409", "report_date": "20190731", "code_info": "All lots beginning with 453091"}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Label Mixup; potentially mislabeled", "address_2": "", "product_quantity": "unknown", "code_info": "Lot # 70926A; Exp. 11/17  Lot # 70981A; Exp. 01/18  Lot # H15A59; Exp. 08/18", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Phenobarbital Tablets USP, 30 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6145-10", "report_date": "20170830", "classification": "Class I", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1112-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040521"], "brand_name": ["PHENYTOIN"], "generic_name": ["PHENYTOIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENYTOIN"], "rxcui": ["1313112"], "spl_id": ["3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26"], "spl_set_id": ["093fd736-5971-47af-b4ef-08c1696cebe8"], "package_ndc": ["51672-4069-1", "51672-4069-2"], "is_original_packager": [true], "upc": ["0351672406929"], "nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "unii": ["6158TKW0C5"]}, "product_type": "Drugs", "event_id": "84916", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0863-2020", "product_description": "Phenytoin Oral Suspension USP, 125 mg/5 mL potency,  8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532,  NDC 51672-4069-1", "product_quantity": "29,172 8 Fl Oz bottles", "reason_for_recall": "Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.", "recall_initiation_date": "20200207", "center_classification_date": "20200302", "termination_date": "20231211", "report_date": "20200304", "code_info": "Lot# 327874, 327876, Exp Dec/2020"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "800", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Ephedrine Sulfate 5 mg/ml in 0.9% Sodium Chloride, 5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0939-70", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1330-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NIFEdipine ER, Tablet, 60 mg may have potentially been mislabeled as the following drug:   NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: W003749, EXP: 6/26/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "NIFEdipine ER, Tablet, 60 mg has the following codes:   Pedigree: W003729, EXP: 6/26/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIFEdipine ER, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591319401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-970-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-931-2015", "product_description": "Tizanidine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "700 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0463-2018", "product_description": "Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75964", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-0245-2017", "product_description": "Torsemide Tablets, 5 mg 100-count bottle, Rx only ,Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9W, 6Y3, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0232-01", "product_quantity": "13,179 bottles (1,317,900 tablets)", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161214", "center_classification_date": "20170102", "termination_date": "20220615", "report_date": "20170111", "code_info": "Lot #: KW8378; Exp. Date 05/17."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "243 vials", "code_info": "Lot #: 20130114-B, Exp 4/14/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Estradiol Valerate Injection, all strengths and all presentations including a) Estradiol Valerate 40-10 mL and b) Estradiol Valerate 40-30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-365-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090999"], "brand_name": ["APREPITANT"], "generic_name": ["APREPITANT"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-2321", "0781-2322", "0781-4063", "0781-2323"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["APREPITANT"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_id": ["a194823e-5961-4bc0-b18f-2f63d3cbb9c6"], "spl_set_id": ["f58b8944-93ee-4be1-a238-cc0061ddd93a"], "package_ndc": ["0781-2321-06", "0781-2321-51", "0781-2322-06", "0781-2322-68", "0781-2322-46", "0781-4063-36", "0781-2323-06", "0781-2323-68"], "is_original_packager": [true], "nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "unii": ["1NF15YR6UY"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1027-2022", "product_description": "Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06", "product_quantity": "29 boxes", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1378-2019", "product_description": "Hemorrhoidal Suppositories (Phenylephrine HCl 0.25%; Hard Fat 88.7%), 12 Rectal Suppositories per carton, NDC: 0536-1389-12, Distributed by Rugby Laboratories, Livonia MI 48152 USA.", "product_quantity": "82,872 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17L008, Exp. 05/2019; 17M019; 17M037, Exp. 06/2019; 18B012; 18K023, Exp. 04/2020."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PHENobarbital, Tablet, 97.2 mg may have potentially been mislabeled as the following drug:  EFAVIRENZ, Capsule, 200 mg, NDC 00056047492, Pedigree: AD46312_31, EXP: 5/16/2014.", "address_2": "", "product_quantity": "1000 Tablets", "code_info": "PHENobarbital, Tablet, 97.2 mg has the following codes:   Pedigree: AD46339_1, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHENobarbital, Tablet, 97.2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603516832.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-992-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]